This case-control study examines the risk of severe COVID-19 infection in individuals with multiple sclerosis who were receiving rituximab.
All Keywords
【초록키워드】 multiple sclerosis, risk, rituximab, COVID-19 infection, case-control study, Severe COVID-19 Infection, individual, receiving, 【제목키워드】 COVID-19, infusion, Multiple, sclerosis, Person,
【초록키워드】 multiple sclerosis, risk, rituximab, COVID-19 infection, case-control study, Severe COVID-19 Infection, individual, receiving, 【제목키워드】 COVID-19, infusion, Multiple, sclerosis, Person,
이 사례 대조 연구는 리툭시맙을 투여받은 다발성 경화증 환자의 심각한 COVID-19 감염 위험을 조사합니다.